Repositioning and Offloading Devices Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Repositioning and Offloading Devices Market in 2025 is evaluated at USD 11.78 billion. The global market size was worth over USD 11.26 billion in 2024 and is poised to grow at a CAGR of around 5.8%, reaching USD 23.43 billion revenue by 2037. North America may generate USD 8.2 billion by 2037, fueled by its robust healthcare system and rising chronic disease cases.
The major factor attributed to the expansion of the global repositioning and offloading devices market is the rising cases of diabetes in the world. Diabetic persons suffer from extreme ulcers owing to poor blood circulation, hyperglycemia, and nerve damage. Thus, for effective treatment, repositioning and offloading devices are used for pressure modulation and mitigation of the pressure from a particular area. As per the World Health Organization (WHO), about 422 million people across the globe suffer from diabetes. Furthermore, it is revealed that almost 1.5 million deaths are directly responsible for diabetes every year worldwide.
The key factor that is estimated to drive market growth during the assessment period is the rising prevalence of pressure and diabetic foot ulcers around the people whole world which require effective repositioning and offloading devices for proper treatment of the pressure. Apart from this, the increased cases of immobility owing to accidents, injuries, and traumas which require repositioning and offloading devices for faster healing are also estimated to create positive opportunities for market growth. Also, the rising number of people with spine and back injuries coupled with the burgeoning geriatric population with musculoskeletal illnesses are projected to bring lucrative growth opportunities for market expansion during the analysis period. Furthermore, the increased investments by major key players in research and investment activities for developing advanced repositioning and offloading devices are also anticipated to create a positive outlook for the growth of the market during the forecast period.
Repositioning and Offloading Devices Sector: Growth Drivers and Challenges
Growth Drivers
-
Growing Prevalence of Obese in the World – Obese people suffer from extreme pressure points owing to their overweight. They require proper treatment for the mitigation of pressure. Thus, the increased prevalence of obesity across the globe is attributed to the growing demand for repositioning and offloading devices in the upcoming years. The data shared by the Centers for Disease Control and Prevention (CDC) stated that the prevalence of obesity in the United States from 2017 to 2020 was 41.9%.
-
High Burden of Ulcers in the Global Economy – Ulcers if not treated properly can lead to internal bleeding, allergies, and other infections. Also, the ulcers create pressure points in the body parts which induces pain, suffering, and discomfort. The use of repositioning and offloading devices helps patients with ulcers to provide comfort and ease the treatment process. Thus, the increasing level of the population with ulcers is projected to create a positive outlook for market expansion. Recently published statistics from 2022 revealed that peptic ulcer disease affects around 4 million people across the globe every year. Also, the estimated lifetime prevalence is projected to be 5-10% in the general population of the world.
-
Increased Prevalence of Chronic Diseases – Owing to sedentary lifestyles, people today are now frequently being diagnosed with chronic diseases including hypertension, cancer, heart diseases, and others. As people with chronic diseases find it difficult to mobility, they need repositioning and offloading devices for proper movement. Also, the demand for repositioning and offloading devices occurs when chronic people undergo surgery and operations for treatment procedures. Therefore, with a high prevalence of chronic diseases in the world, the demand for repositioning and offloading devices is also expected to increase considerably in the near future. The data published in 2022 stated that in the United States, approximately 133 million suffer from at least one chronic disease including hypertension, heart disease, and arthritis. Furthermore, this figure is estimated to grow rapidly and reach around 170 million by 2030.
-
Rising Focus on Adopting Advanced Medical Products – With the rapid increase of income levels, the per capita income along with healthcare expenditure also rose. This has prompted in rising focus on adopting advanced medical products for treatment processes including repositioning and offloading devices. Therefore, with an increase in healthcare expenditure, the production level of repositioning and offloading devices rose for treatment procedures. The World Health Organization (WHO) stated that the global healthcare expenditure in 2020 was expected to be accounted for around 11% of the global GDP which is equivalent to USD 9 trillion.
-
The Surge in Back and Spinal Injury – The World Health Organization (WHO) stated that approximately 250,000 to 500,000 patients have a spinal cord injury every year around the globe.
-
Burgeoning Geriatric Population – The Department of Economic and Social Affairs, United Nations exclaimed that in 2019, there were 703 million populations with age 65 years and above worldwide. Gradually, this figure is estimated to escalate and reach 1.5 billion by 2050.
Challenges
-
High Costs of Repositioning and Offloading Devices – Repositioning and offloading devices are integrated with advanced features and technologically developed systems. Thus, the price of end-products has subsequently risen. This factor is anticipated to lower the adoption rate of repositioning and offloading devices among lower and middle-income people. Ultimately, this hampers the expansion of the market growth during the analysis period.
-
Low Level of Awareness Regarding the Advantages
-
Increased Costs in the Healthcare Sector
Repositioning and Offloading Devices Market : Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.8% |
|
Base Year Market Size (2024) |
USD 11.26 billion |
|
Forecast Year Market Size (2037) |
USD 23.43 billion |
|
Regional Scope |
|
Repositioning and Offloading Devices Segmentation
Application (Surgery, Diagnostics)
The global repositioning and offloading devices market is segmented and analyzed for demand and supply by application in surgery and diagnostics. Out of these two segments, the surgery segment is attributed to the largest share of the market by the end of 2037. The major factor that is projected to escalate a robust revenue generation is the high number of surgeries being performed every day around the world. As individuals after surgeries suffer from weakness, unconsciousness, semi-paralysis, and others that reduce the movement of individuals require repositioning and offloading devices for help. The National Library of Medicine released surgical data in 2020 stating that more than 310 million major surgeries are conducted every year across the world. Out of these, 40 to 50 million surgeries are performed in the United States and 20 million in Europe. Also, with the rising prevalence of chronic diseases along with non-communicable disorders, the number of surgeries being performed has increased considerably which has resulted in high demand for repositioning and offloading devices for enhanced patient experience and ease of movement.
End-user (Hospitals, Ambulatory Surgery Centers, Skill Nursing Facilities)
The global repositioning and offloading devices market is also segmented and analyzed for demand and supply by end-user in hospitals, ambulatory surgery centers, and skilled nursing facilities. Out of these three segments, the hospitals segment is projected to hold a significant share with a notable CAGR value during the assessment period. The major factors for segment growth are the rising number of hospitals across the globe and rising investments in enhancing hospital settings. Furthermore, the increased flow of inpatients and outpatients in hospitals across the globe for diagnosis and treatment is expected to increase the utilization rate of repositioning and offloading devices in hospitals. Recent data published that in 2020, the number of outpatient visits in the hospitals present in the United States was calculated to be approximately 780 million, out of which around 750 million visits took place in general medical and surgical hospitals. Also, the availability of the newest technology and highly-developed medical devices including repositioning and offloading devices is expected to create a positive outlook for segment growth during the next few years.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Repositioning and Offloading Devices Industry - Regional Synopsis
North American Market Forecast
North America industry is poised to hold largest revenue share of 35% by 2037. The growth of the market can be attributed majorly to the back of developed healthcare infrastructure in the region. Furthermore, the rising chronic diseases and non-communicable disorders have propelled the burden of pressure injuries in the human body. The report published by National Centre for Biotechnology Information apprises that pressure injuries of soft tissues and skin affect approximately 1 to 3 million people in the USA each year, which is the reason government is proactive to prevent such adversities. Furthermore, the rising government initiatives along with the rising healthcare expenditure and increased focus on adopting medical devices for enhancing the patients’ experience are considered to be other factors for fueling the expansion of the market size of the North American repositioning and offloading devices market over the forecast period.
APAC Market Statistics
On the other hand, the repositioning and offloading devices market in the Asia Pacific region is also expected to thrive over the forecast period owing to the increasing number of diabetic patients. Along with diabetes, other chronic diseases such as cancers, and hypertension has escalated pressure points and other musculoskeletal diseases which require repositioning and offloading devices for enhanced mobility of the patients. According to data published by World Health Organization, in India alone, 8.7% of the population between the ages of 20 to 70 is diabetic. Furthermore, in China also it is estimated that approximately 1 billion people aged between 20 to 79 are suffering from diabetes.
Companies Dominating the Repositioning and Offloading Devices Landscape
- Molnlycke Health Care AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- PfBeechfield Healthcare Ltd
- V Guldmann A/S
- Sage Products LLC
- Hill-Rom Services, Inc.
- Frontier Medical Group
- Walgreen Health Solutions, LLC.
- Stryker Corporation
- Seneca Devices, Inc.Â
Recent Developments
-
 Beech field Healthcare collaborated with Tallaght University Hospital (TUH) and went live to demonstrate Total Bed Management Solutions.
-
Baxter International, announced that they are innovating a technologically advanced medication delivery system called Sigma Spectrum, which is a large-volume infusion pump.
- Report ID: 4091
- Published Date: Apr 23, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Repositioning and Offloading Devices Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
